Legislation Would Keep CGMs, Insulin Pumps out of Competitive Bidding

WASHINGTON—Sens. Jeanne Shaheen and Susan Collins, co-chairs of the Senate Diabetes Caucus, have introduced legislation aimed at improving access to diabetes technologies that includes provisions to keep insulin pumps and continuous glucose monitors (CGMs) out of the durable medical equipment, prosthetics and orthotics (DMEPOS) competitive bidding program for five years.

The Diabetes Interventions Addressing Barriers to Enrollment, Technology and Education Services Act (Diabetes Act), S 4037, also expands Medicare coverage of diabetes self-management training sessions, where diabetes educators help train Medicare patients on how to manage the disease and use complex diabetes technologies.

“Senators Shaheen and Collins have a long record of standing by the millions of Americans who use diabetes products and working to ensure they can benefit from continuing technological advances for these devices,” said Tom Ryan, AAHomecare president & CEO.

“I know that diabetes stakeholders in our industry are ready to engage their legislators on this issue,” Ryan continued. “That enthusiasm, coupled with the support from leading diabetes advocacy groups who have endorsed this bill, will make a strong impact on Capitol Hill.”

Full text of the legislation can be found here.